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ARTHRITIS & OSTEOPOROSIS—Quality of Life
Presentations
PAO12
WEB-BASED HEALTH STATUS ASSESSMENT OF
A NATIONALLY REPRESENTATIVE SAMPLE OF
ELDERLY OSTEOARTHRITIC PATIENTS
Madnani DM1, Nayak RA1,Ward J2
1St. John’s University, Jamaica, NY, USA; 2Knowledge Networks
Inc, New York, NY, USA
OBJECTIVES: Assessment of health-related quality of life
(HRQOL) of elderly osteoarthritic patients and descrip-
tion of their use of prescription drugs, OTC medications,
and herbal remedies.
METHODS: Online survey methodology utilizing
WebTV technology and Random Digit Dialing (RDD)
procedures was implemented. Short Form 36 (SF-36)
health status instrument was administered to a panel of
elderly arthritic patients (N = 550), recruited randomly
from 44 states in the US. Summary physical and mental
component scores (PCS and MCS), and domain scores on
eight SF-36 subscales were computed.
RESULTS: A response rate of 87.27% (N = 480) was
achieved following the online administration of the
survey in August 2001. Osteoarthritis (OA) was previ-
ously diagnosed in 42.3% (N = 203) of the sample.
Rheumatoid Arthritis was diagnosed in 16.5% of the
sample. In the OA sample, 21.7% of the subjects also had
osteoporosis. In general, males reported higher health
status scores than females on physical functioning (PF),
bodily pain (BP), social functioning (SF), and role physi-
cal (RP) domains of SF-36. Compared to the norms for
the general US populations, our OA sample reported
lower mean scores on ﬁve of the eight SF-36 domains.
Respondent age was negatively correlated with both PCS
(r = -0.196) and MCS (r = -0.179). PCS correlated sig-
niﬁcantly with both income and education variables (r =
0.012 and r = 0.027 respectively). Sixty two percent of
the sample reported having used OTC acetaminophen to
treat arthritis, while 29% of the sample was currently
using COX-2 inhibitors. Ninety percent of the sample had
tried an alternative remedy such as Chondroitin and 
Glucosamine Sulfate during the past 2 years.
CONCLUSIONS: Elderly patients with osteoarthritis
reported poorer HRQOL compared to the elderly in the
general US population. Preference for and use of nonpre-
scription medications, particularly alternative remedies,
appears to be quite common among elderly osteoarthritic
patients.
PAO13
VALIDATION OF A PATIENT QUESTIONNAIRE
TO ASSESS OSTEOPOROSIS-RELATED
ATTITUDES, KNOWLEDGE AND BEHAVIOR
Brenneman SK1, Blau EM2, Chen YT1,Abbott TA1
1Merck & Co., Inc, West Point, PA, USA; 2Kaiser Permanente—
Southern California, San Diego, CA, USA
OBJECTIVE: The questionnaire, “Osteoporosis and
You”, is a 20-item self-report questionnaire designed to
assess the attitude, knowledge and behavior of women
about osteoporosis. The items are grouped to form three
sections hypothesized to assess different domains: Knowl-
edge, Attitude/Actions related to Osteoporosis, and
Health Behavior. This study examined the validity of the
questionnaire in a patient population.
METHODS: 500 women over the age of 20 were
recruited consecutively during January 2001 until there
were 100 women in each age cohort (under 40, 40–49,
50–59, 60–69, and 70+). Validity was examined by item
analysis, internal consistency, conﬁrmatory factor analy-
sis, and hypothesized relationships between responses
and demographics.
RESULTS: Of the 500 respondents, 76% were 
Caucasian, 9% Hispanic, 6.4% African-American and
5.4% Asian. The responses to the Knowledge items indi-
cated overall awareness and knowledge of osteoporosis.
Response distribution varied across age groups. The
Action section showed a hierarchical pattern consistent
with increasing level of intervention. Greater than 50%
of respondents were concerned that she might get/have
osteoporosis and only 6% were prescribed medication for
osteoporosis. The item responses for the Behavior section
were distributed across the scale. Good internal consis-
tency was found (Cronbach’s alpha = 0.75). Conﬁrma-
tory factor analysis supported the division of the
questionnaire into the three sections. Hypothesized rela-
tionships among responses and demographics were sup-
ported. Results show signiﬁcant differences in Knowledge
and Behavior by age group. Women <50 years were less
knowledgeable and demonstrated fewer behaviors than
women 60+ years of age. There were also differences in
Knowledge and Behavior related to the level of response
to Action items.
CONCLUSION: The results of this study support the use
of the questionnaire to obtain information about current
knowledge of women about osteoporosis, from which
educational interventions could be customized. Conﬁr-
mation of the ﬁndings in populations of different charac-
teristics merits further investigation.
PAO14
APPLICATION OF RASCH ANALYSIS IN
COMPARISON OF SELF-ASSESSED HEALTH
STATUS ACROSS TWO ARTHRITIS CONDITIONS
USING A GENERIC HEALTH STATUS SURVEY
Dalal M, Basu S, Smith E
University of Illinois at Chicago, Chicago, IL, USA
OBJECTIVES: To psychometrically test a generic health
status scale in patients with osteo-(OA) and rheumatoid
arthritis (RA) using Rasch analysis and; compare health
status impairment and identify differential item function-
ing across two arthritis conditions.
METHODS: Data from 101 OA, and 78 RA patients
from the Household Component of 1996 Medical Expen-
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diture Panel Survey (MEPS) was analyzed. Rasch Rating
Scale model was used. Fit statistic and PC analysis of
residuals evaluated unidimensionality of 21-item scale 
for each group. Item and rating scale functioning were
compared across groups by independent t-tests and 
correlations.
RESULTS: Person separation was 1.93 in OA patients
and 2.40 in RA. For both groups, the item on perceived
mental health had high INFIT/OUTFIT MNSQ (>1.4),
while activity limitation item displayed overﬁt
(INFIT/OUTFIT MNSQ <0.6). Analysis demonstrated
congruent item hierarchies in both conditions. Invariance
in item difﬁculties and rating scale step measures was
revealed by non-signiﬁcant (alpha = 0.05) t-statistic.
CONCLUSIONS: Instrument functioned satisfactorily in
both groups. Nineteen items showed adequate ﬁt with
unidimensional requirements. No conclusive difference 
in interpretation of items or response categories was
observed. Patients with OA and RA demonstrated iden-
tical health functional impairments. Therefore, scale
appears to be applicable and measures equivalently in OA
and RA.
PAO15
IMPACT OF ETANERCEPT FOR RHEUMATOID
ARTHRITIS (RA) ON HEALTH-RELATED
QUALITY OF LIFE (HRQOL) AND FUNCTIONAL
STATUS IN A NATURALISTIC SETTING
Kamikawa BF,Wanke LA
Immunex Corporation, Seattle, WA, USA
In clinical trials, etanercept has been shown to improve
health outcomes and functional status. This observational
study was undertaken to evaluate etanercept in a non-trial
(naturalistic) setting.
OBJECTIVE: To analyze the impact of etanercept on
HRQOL and functional status in persons with RA in a
naturalistic setting.
METHODS: 1043 persons with RA and on etanercept
therapy were followed in an observational, longitudinal
study. HRQOL and functional status data was obtained
via mailed questionnaires at baseline and at 6 months.
Vitality and mental health was measured by domain ques-
tions on the Medical Outcomes Study Short Form 36 (SF-
36). Functional outcomes were measured by the Health
Assessment Questionnaire (HAQ).
RESULTS: 82.3% of the sample were women. The mean
age was 54 years. Both the SF-36 vitality and mental
health domain scores had clinically meaningful improve-
ments. The mean score at baseline for vitality was 30.3
units (0–100, 100 = no impairment) and mental health
was 58.0 units. At 6 months, vitality improved by 20.5
units and mental health improved by 13.4 units. 70.6%
of the sample for vitality and 53.3% for mental health
experienced clinically meaningful improvements of at
least 10 units at 6 months. The mean HAQ index at base-
line was 1.54 units (0–3, 3 = greatest disability). At 6
months follow-up, the mean index decreased (improved)
by 0.68 units. At the 6 month follow-up, 77.9% of the
sample experienced a clinically meaningful improvement
in HAQ index of 0.25 units or greater. Additionally,
10.6% achieved a zero HAQ index and 36.9% achieved
an index of 0.5 units or less.
CONCLUSION: In this naturalistic study, etanercept
demonstrated signiﬁcant improvement in HRQOL and
functionality, as measured by the SF-36 and HAQ.
PAO16
RISK OF CLINICAL DEPRESSION IN ARTHRITIS:
A WEB-BASED CO-ADMINISTRATION OF CESD-
20 AND SF-36 TO A NATIONALLY
REPRESENTATIVE ELDERLY SAMPLE
Nayak RA1, Madnani DM1,Ward J2
1St. John’s University, Jamaica, NY, USA; 2Knowledge Networks
Inc, New York, NY, USA
OBJECTIVES: To utilize WebTV technology to measure
depression in arthritic patients using Center for Epidemi-
ological Studies Depression Scale (CESD-20) and to assess
health related quality of life (HRQOL) using Short Form
36 (SF-36).
METHODS: Random Digit Dialing (RDD) survey 
procedures were used to recruit individuals previously
diagnosed with arthritis (N = 550), drawn from US house-
holds across 44 states. Each participating household was
outﬁtted with a free WebTV and internet connection.
Cut-off scores of <52 and >16 were used on the Mental
Health (MH) subscale of SF-36 and CESD-20, respec-
tively, to identify arthritic patients at risk for clinical
depression.
RESULTS: A response rate of 87% (N = 480) was
achieved following the administration of surveys in
August 2001. Using CESD scores, 16% (n = 76) of the
respondents were found to be at risk for clinical depres-
sion, as opposed to only 4% (n = 19) of the subjects who
scored below the cutpoint on the MH subscale of SF-36.
A strong negative correlation (r = -0.68) was found
between the CESD sum of scores and MH domain scores.
Signiﬁcant differences on the CESD scores were found
between different age groups, for both males and females,
and between groups previously diagnosed with osteo-
arthritis and rheumatoid arthritis.
CONCLUSIONS: While concurrent administration of
SF-36 and CESD-20 in patients with a chronic disease 
is desirable for simultaneous assessment of health status
and depressive symptomatology, conﬂicting results are
possible when the two instruments measure the same 
criterion. SF-36 and CESD-20 lead to differential assess-
ment of depression resulting in a discrepancy in the 
measurement.
